SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The crow with knife community is actively celebrating the project's two-year anniversary while highlighting its multi-chain presence and deflationary tokenomics. Investors remain vocal about upcoming developments and the strength of their organic, community-driven approach.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu is capturing significant community attention as a brand-driven project focusing on organic, community-led product initiatives and IRL events. Supporters emphasize the project's consistent building efforts, widespread merchandise, and the conviction of its members as key drivers for long-term growth across multiple chains.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin (XCN) is currently experiencing heightened community engagement and price volatility as traders closely monitor the upcoming Goliath mainnet launch. While some investors remain optimistic about the project's roadmap and potential for real-world asset tokenization, others are expressing skepticism and caution due to historical price trends and persistent concerns regarding transparency.

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in May 2012 and is headquartered in Kansas City, KS.

Cingulate Inc

Cingulate Inc. is trending as investors aggressively accumulate shares in anticipation of critical upcoming catalysts, including imminent U.S. patent news and a final FDA approval decision scheduled for May 31, 2026. The community sentiment is highly optimistic, with many citing the company's proprietary Precision Timed Release technology as a potential game-changer in the massive ADHD market and debating the prospects of a strategic partnership or buyout.

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Clene Inc

Clene Inc. is trending as investors aggressively position themselves ahead of a pivotal regulatory milestone, with the community closely tracking the expected submission of an NDA for accelerated approval in ALS. Enthusiastic sentiment is fueled by anticipation of upcoming clinical biomarker data and the potential for a significant re-rating, though some investors remain cautious about the company's cash runway and the history of volatility surrounding speculative biotech catalysts.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore Corp. (SOC) is currently the focal point of a high-stakes standoff between the Trump administration and California regulators, as federal authorities invoke the Defense Production Act to bypass state-level safety injunctions and fast-track the restart of the Santa Ynez pipeline. The stock is experiencing significant volatility and high trading volume as investors closely watch the legal battle between federal preemption and state environmental protections, with many in the community betting on a potential short squeeze while others raise alarms about the company's precarious financial position and regulatory hurdles.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is currently trending as investors monitor ongoing discussions with the FDA regarding the clinical hold on its Phase 3 MAGNITUDE trials. The community is actively debating the stock's high short interest and the potential for a rapid recovery, with many focused on the upcoming clinical data readouts as a key catalyst.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is facing intense volatility as investors debate the sustainability of its valuation relative to its current revenue, leading to a polarizing mix of aggressive shorting and speculation ahead of its upcoming earnings report. The community remains deeply divided, with some highlighting the company's long-term potential in quantum infrastructure and recent government contract activity, while vocal critics focus on its significant cash burn and a valuation they argue is disconnected from fundamental performance.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluence Energy is drawing significant investor interest as the company shifts from recent margin-related volatility to a narrative of robust backlog growth and expanding data center demand, buoyed by positive analyst upgrades and a record-high order intake. The community is actively debating the company's potential as a critical infrastructure play for AI-driven power needs, with many focusing on whether recent operational improvements will finally bridge the gap between their massive project pipeline and sustained profitability.

Bank of America Corp. is a bank and financial holding company, which engages in the provision of banking and nonbank financial services. It operates through the following segments: Consumer Banking, Global Wealth and Investment Management (GWIM), Global Banking, Global Markets, and All Other. The Consumer Banking segment offers credit, banking, and investment products and services to consumers and small businesses. The GWIM segment focuses on solutions to meet clients’ needs through a full set of investment management, brokerage, banking, and retirement products. The Global Banking segment deals with lending-related products and services, integrated working capital management and treasury solutions to clients, and underwriting and advisory services. The Global Markets segment includes sales and trading services, as well as research, to institutional clients across fixed-income, credit, currency, commodity, and equity businesses. The All Other segment consists of asset and liability management activities, equity investments, non-core mortgage loans and servicing activities, the net impact of periodic revisions to the mortgage servicing rights valuation model for both core and non-core MSRs, other liquidating businesses, residual expense allocations and other. The company was founded by Amadeo Peter Giannini in 1904 and is headquartered in Charlotte, NC.

Bank Of America Corp.

Bank of America Corp

Bank of America is currently trending as investors balance strong quarterly performance and resilient NII growth forecasts against heightened volatility surrounding potential credit card interest rate caps. The community remains deeply divided, with some traders hunting for entries on earnings-related pullbacks while others express significant concern over the broader systemic risks posed by the private credit market and regulatory uncertainty.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$KROS skyrocketed 85.6% in a year — what&#39;s fueling the rally? 🚀

📈 Strategic review + pipeline progress = investor enthusiasm
💊 Key developments: KER-065 for DMD and elritercept licensing with Takeda
💰 Valuation: Trading at 0.85x tangible book value based on the price/book ratio, well below industry average

With a Zacks Rank #1, find out if KROS is a hidden gem 👉 https://www.zacks.com/stock/news/2817957/kros-stock-surges-856-in-a-year-more-upside-potential-in-2026?cid=sm-stocktwits-2-2817957-body-29113&amp;ADID=SYND_STOCKTWITS_TWEET_2_2817957_BODY_29113

Emil

Hans Gruber

Zacks

Pardon Our Interruption

Zacks Research

Keros Therapeutics Inc

 skyrocketed 85.6% in a year — what's fueling the rally? 🚀

📈 Strategic review + pipeline progress = investor enthusiasm
💊 Key developments: KER-065 for DMD and elritercept licensing with Takeda
💰 Valuation: Trading at 0.85x tangible book value based on the price/book ratio, well below industry average

With a Zacks Rank #1, find out if KROS is a hidden gem 👉 

This account is recognized as an Official Stocktwits Research Partner — working in close collaboration with Stocktwits to deliver in-depth research and market analysis.